Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 17, 2024
- Accession no.
- 0001562180-24-008451
- Filed
- Dec 17, 2024
- Trade date
- Dec 16, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 16 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.70M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Common Stock | MOption exerciseAcquired | +3,352 | $111.00 | +$372,072 | 3,352 | Indirect | |
| Dec 16, 2024 | Common Stock | MOption exerciseAcquired | +4,148 | $111.00 | +$460,428 | 7,500 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −100 | $363.25 | −$36,325 | 7,400 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −100 | $364.97 | −$36,497 | 7,300 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −768 | $367.70 | −$282,393.6 | 6,532 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −1,336 | $368.94 | −$492,903.84 | 5,196 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −1,510 | $369.90 | −$558,549 | 3,686 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −1,981 | $370.96 | −$734,871.76 | 1,705 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −1,644 | $372.18 | −$611,863.92 | 61 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −61 | $372.60 | −$22,728.6 | 0 | Indirect | |
| Dec 16, 2024 | Common Stock | MOption exerciseAcquired | +2,500 | $111.00 | +$277,500 | 2,500 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −100 | $363.25 | −$36,325 | 2,400 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −300 | $368.16 | −$110,448 | 2,100 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −800 | $369.57 | −$295,656 | 1,300 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −800 | $370.93 | −$296,744 | 500 | Indirect | |
| Dec 16, 2024 | Common Stock | SSaleDisposed | −500 | $372.15 | −$186,075 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Common Stock | MOption exerciseDisposed | −3,552 | $0.00 | $0 | 82,179 | Indirect | |
| Dec 16, 2024 | Common Stock | MOption exerciseDisposed | −4,148 | $0.00 | $0 | 0 | Indirect | |
| Dec 16, 2024 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 29,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.